Quanterix
Christopher Zarozinski, PhD, is a Senior Scientist at Quanterix since March 2018, currently leading the development and validation of multiplexed chemiluminescent ELISA biomarker assays. Previously, at Aushon BioSystems, Christopher facilitated the validation and transfer of Laboratory Developed Tests and contributed to the launch of the CiraPlex®ULTRA assay series. Christopher has extensive experience in biomarker research, having held senior scientific roles at Courtagen Life Sciences, Decision Biomarkers, Schleicher & Schuell BioScience, and AltaRex Corporation. Christopher earned a PhD in Immunology from Harvard Medical School and holds a BS in Biology from Worcester Polytechnic Institute.
This person is not in any teams
Quanterix
3 followers
Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health.